Diagnostic Evidence, Detailed Explanation
Diagnostic Evidence, Detailed Explanation
The submitted content consists of patient-specific clinical records for Maria Lamantia and broader medical evidence supplements regarding Supraventricular Tachycardia (SVT). Below are the medically relevant data and the source materials indicated.
1. Source Material Identified
The documents indicate the following specific sources of information used to compile the patient’s medical profile:
- Imaging Reports: A CT Head Without Contrast from Alameda Health System dated July 8, 2024 [1, 2].
- Electrocardiography (ECG): Serial readings, including a critical 12-lead ECG and ambulatory ECGs, dating from July 2024 to December 10, 2025 [3-6].
- Laboratory Data: CBC and iron studies from February 19, 2025, and September 3, 2025; oncology labs from November 24, 2025; and flow cytometry and molecular testing (JAK2/BCR-ABL) from early 2025 [1, 3, 7, 8].
- Genetic Testing: Invitae hereditary cancer panels (70-gene panel) and reports from direct-to-consumer services (23andMe, Nebula, Sequencing.com) [2, 3, 9].
- Clinical Summaries: An HL7 CDA encounter summary from John Muir Health (July 20, 2025) and a progress note from an infusion event on November 3, 2025 [1, 10, 11].
- Wearable Technology: Data derived from Apple Health and Apple Watch monitoring for Heart Rate Variability (HRV), stress, and nocturnal oxygen saturation [12, 13].
- Reference Guidelines: The 2015 SVT Guideline Data Supplement, which provides evidence-based outcomes for pharmacological and catheter therapies [14, 15].
2. Medically Relevant Patient Data
The sources detail a multisystem profile characterized by acute cardiovascular instability and chronic hematologic and neurological concerns.
Cardiovascular and Respiratory Data
- Emergent Electrical Instability: A malignant Long QT phenotype with a peak QTc $\geq$ 612 ms (documented as high as 617 ms in December 2025) [3, 5, 16]. This places the patient at imminent risk for Torsades de Pointes (TdP) and Sudden Cardiac Death (SCD) [5, 17, 18].
- Hemodynamic Stress: Persistent Stage 1-2 Hypertension (e.g., 166/97 mmHg) and signs of high-output strain with a heart rate of 107–118 bpm [3, 5, 13, 19].
- Arrhythmias: Documented episodes of Paroxysmal Atrial Fibrillation (AFib), Non-sustained Ventricular Tachycardia (NSVT), and frequent premature ventricular contractions (PVCs) [1, 3, 17].
- Respiratory Compromise: Resting hypoxemia (SpO₂ 89%) and tachypnea (24 bpm), with suspected Obstructive Sleep Apnea (OSA) given a BMI of 35.6 and reports of nocturnal desaturations [13, 17, 20, 21].
Hematologic and Oncologic Data
- Severe Iron-Deficiency Anemia: Laboratory confirmed with Ferritin at 6 ng/mL and Hemoglobin falling to 10.9 g/dL [8, 22].
- Reactive Changes: Persistent leukocytosis (WBC up to 16.43 $\times 10^3/\mu$L) and thrombocytosis (Platelets up to 640 $\times 10^3/\mu$L), which are considered reactive to the anemia and inflammation [3, 7, 8, 22].
- Malignancy Workup: Investigations for multiple myeloma/plasma cell disorders due to abnormal protein bands, with a bone marrow biopsy scheduled for December 2025 [19]. Molecular tests for primary myeloproliferative disorders were negative [7, 23].
Neurological and Metabolic Data
- Cerebrovascular Changes: CT findings of mild white matter hypoattenuation indicative of chronic small vessel ischemic disease, which is noted as atypical for the patient’s age (39) [2, 3, 22, 24].
- Seizure History: A history of seizures, including an episode during a sepsis event in July 2024 that was accompanied by lactic acidosis (4.4 mmol/L) and hepatic injury [1, 3, 20].
- Metabolic Status: Class II Obesity (BMI 35.11–35.6) and Pre-diabetes (Glucose 114 mg/dL) [1, 3, 20].
Allergies and Genetic Risk
- Severe Adverse Reaction: A documented contraindication to Ferric Derisomaltose (Monoferric) following an acute allergic reaction involving throat swelling and generalized itching on November 3, 2025 [7, 10, 25, 26].
- Genetic Panel Results: Clinical-grade testing detected no pathogenic variants or variants of uncertain significance (VUS) across 70 genes, despite a significant multi-generational family history of kidney, colon, pancreatic, and stomach cancers [2, 3, 9].
Analogy for Cardiovascular State:
The patient’s heart is currently like a house with both faulty wiring and a failing power grid. The Long QT interval (the wiring) is prone to “short-circuiting” into a deadly rhythm, while the chronic hypertension and anemia (the grid) keep the entire system under a constant, high-pressure load that prevents it from ever cooling down.
Source Material Identified
- Patient-specific clinical records for Maria Lamantia
- Broader medical evidence supplements related to Supraventricular Tachycardia (SVT)
- Key source categories used to compile the patient’s profile:
- Imaging Reports
- CT Head Without Contrast from Alameda Health System dated July 8, 2024 [1, 2]
- Electrocardiography (ECG)
- Serial ECG readings, including a critical 12-lead ECG and ambulatory ECGs
- Dates span July 2024 to December 10, 2025 [3-6]
- Laboratory Data
- CBC and iron studies from February 19, 2025 and September 3, 2025
- Oncology labs from November 24, 2025
- Flow cytometry and molecular testing (JAK2/BCR-ABL) from early 2025 [1, 3, 7, 8]
- Genetic Testing
- Invitae hereditary cancer panel (70-gene panel)
- Direct-to-consumer reports from 23andMe, Nebula, and Sequencing.com [2, 3, 9]
- Clinical Summaries
- HL7 CDA encounter summary from John Muir Health dated July 20, 2025
- Progress note from an infusion event on November 3, 2025 [1, 10, 11]
- Wearable Technology
- Data from Apple Health and Apple Watch
- Metrics include Heart Rate Variability (HRV), stress, and nocturnal oxygen saturation [12, 13]
- Reference Guidelines
- 2015 SVT Guideline Data Supplement
- Evidence-based outcomes for pharmacological and catheter therapies [14, 15]
- Imaging Reports
Medically Relevant Patient Data
Cardiovascular and Respiratory Data
-
Emergent electrical instability
- Malignant Long QT phenotype
- Peak QTc ≥ 612 ms, documented as high as 617 ms in December 2025 [3, 5, 16]
- Described as placing the patient at imminent risk for:
- Torsades de Pointes (TdP)
- Sudden Cardiac Death (SCD) [5, 17, 18]
-
Hemodynamic stress
- Persistent Stage 1–2 hypertension
- Example: 166/97 mmHg [3, 5, 13, 19]
- Signs of high-output strain
- Heart rate reported at 107–118 bpm [3, 5, 13, 19]
- Persistent Stage 1–2 hypertension
-
Arrhythmias
- Documented episodes of:
- Paroxysmal Atrial Fibrillation (AFib)
- Non-sustained Ventricular Tachycardia (NSVT)
- Frequent premature ventricular contractions (PVCs) [1, 3, 17]
- Documented episodes of:
-
Respiratory compromise
- Resting hypoxemia with SpO₂ 89%
- Tachypnea at 24 bpm
- Suspected Obstructive Sleep Apnea (OSA)
- Supported by BMI 35.6
- Reports of nocturnal desaturations [13, 17, 20, 21]
Hematologic and Oncologic Data
-
Severe iron-deficiency anemia
- Ferritin 6 ng/mL
- Hemoglobin down to 10.9 g/dL [8, 22]
-
Reactive changes
- Persistent leukocytosis
- WBC up to 16.43 × 10^3/μL [3, 7, 8, 22]
- Persistent thrombocytosis
- Platelets up to 640 × 10^3/μL [3, 7, 8, 22]
- Interpreted as reactive to anemia and inflammation
- Persistent leukocytosis
-
Malignancy workup
- Evaluation for multiple myeloma / plasma cell disorders
- Triggered by abnormal protein bands
- Bone marrow biopsy scheduled for December 2025 [19]
- Molecular tests for primary myeloproliferative disorders were negative [7, 23]
Neurological and Metabolic Data
-
Cerebrovascular changes
- CT shows mild white matter hypoattenuation
- Interpreted as chronic small vessel ischemic disease
- Noted as atypical for the patient’s age (39) [2, 3, 22, 24]
-
Seizure history
- History of seizures
- One episode occurred during a sepsis event in July 2024
- Associated findings included:
- Lactic acidosis (4.4 mmol/L)
- Hepatic injury [1, 3, 20]
-
Metabolic status
- Class II obesity
- BMI 35.11–35.6 [1, 3, 20]
- Pre-diabetes
- Glucose 114 mg/dL [1, 3, 20]
- Class II obesity
Allergies and Genetic Risk
-
Severe adverse reaction
- Documented contraindication to Ferric Derisomaltose (Monoferric)
- Reaction on November 3, 2025
- Symptoms included:
- Throat swelling
- Generalized itching [7, 10, 25, 26]
-
Genetic panel results
- Clinical-grade testing found no pathogenic variants
- Also found no variants of uncertain significance (VUS) across 70 genes [2, 3, 9]
- This was despite a strong multi-generational family history of:
- Kidney cancer
- Colon cancer
- Pancreatic cancer
- Stomach cancer
Interpretive Summary
-
The patient’s profile suggests a multisystem condition involving:
- Significant electrical cardiac instability
- Anemia-related physiologic stress
- Possible sleep-disordered breathing
- Ongoing hematologic/oncologic evaluation
- Neurologic and metabolic comorbidities
-
The most urgent cardiovascular issue is the marked QT prolongation, which creates high risk for malignant arrhythmias.
-
The anemia, hypertension, obesity, and arrhythmia burden likely contribute to the overall cardiovascular strain.
-
Negative molecular testing lowers suspicion for certain myeloproliferative disorders, but the abnormal protein bands and planned bone marrow biopsy indicate unresolved diagnostic concern.
Key Takeaways
- QTc prolongation is severe and places the patient at high risk for TdP and SCD.
- The patient has multiple concurrent cardiovascular stressors, including hypertension, tachycardia, AFib, NSVT, and PVCs.
- Iron-deficiency anemia is significant and likely contributes to reactive leukocytosis and thrombocytosis.
- There is ongoing workup for possible plasma cell or other hematologic disorders, despite negative myeloproliferative molecular tests.
- A serious infusion-related allergy to ferric derisomaltose and a strong family cancer history are important considerations in management.
What is the most important cardiac abnormality described in the record?
A malignant Long QT phenotype, with a peak QTc reported as high as 617 ms. This is a dangerous repolarization abnormality associated with a high risk of torsades de pointes and sudden cardiac death.
Why is a markedly prolonged QTc clinically dangerous?
A very prolonged QTc increases the risk of torsades de pointes, a potentially fatal ventricular arrhythmia. It can also predispose to sudden cardiac death, especially when combined with other stressors or electrolyte issues.
What arrhythmias were documented in addition to Long QT?
The record describes paroxysmal atrial fibrillation, non-sustained ventricular tachycardia, and frequent premature ventricular contractions. These findings indicate electrical instability affecting both atrial and ventricular rhythm.
What blood pressure pattern was reported?
Persistent stage 1-2 hypertension was reported, including readings such as 166/97 mmHg. This suggests chronic hemodynamic stress.
What signs suggest increased cardiovascular strain or demand?
The patient had tachycardia, with heart rates around 107–118 bpm, along with hypertension and anemia. Together, these findings suggest a high-output physiologic stress state.
What respiratory abnormalities were noted?
Resting hypoxemia with SpO₂ 89% and tachypnea at 24 breaths per minute were reported. These findings suggest impaired oxygenation and increased respiratory effort.
Why is obstructive sleep apnea suspected in this patient?
Suspicion is based on obesity, reported nocturnal desaturations, and low oxygen saturation. OSA can worsen cardiovascular strain and arrhythmia risk.
What was the patient’s BMI range, and why does it matter?
The BMI was reported around 35.11–35.6, consistent with class II obesity. Obesity increases risk for hypertension, sleep apnea, metabolic dysfunction, and arrhythmias.
What hematologic abnormality was confirmed by labs?
Severe iron-deficiency anemia was confirmed, with ferritin at 6 ng/mL and hemoglobin down to 10.9 g/dL. This can contribute to fatigue, tachycardia, and physiologic stress.
What reactive blood count changes were observed?
Persistent leukocytosis and thrombocytosis were reported, with WBC up to 16.43 × 10^3/μL and platelets up to 640 × 10^3/μL. These were considered reactive, likely related to anemia and inflammation.
What malignancy-related workup was being considered?
The patient was being evaluated for multiple myeloma or another plasma cell disorder because of abnormal protein bands. A bone marrow biopsy was scheduled for December 2025.
What did the molecular testing for myeloproliferative disorders show?
Molecular tests for primary myeloproliferative disorders were negative, including JAK2 and BCR-ABL testing. This makes a primary myeloproliferative neoplasm less likely.
What brain imaging abnormality was noted on CT head?
CT head showed mild white matter hypoattenuation consistent with chronic small vessel ischemic disease. This was noted as atypical for the patient’s age.
What neurological history was documented in the record?
The patient has a seizure history, including an episode during sepsis in July 2024. That event was associated with lactic acidosis and hepatic injury.
What metabolic conditions were documented?
Class II obesity and pre-diabetes were noted, including a glucose of 114 mg/dL. These conditions increase cardiometabolic risk.
What serious drug reaction was documented?
Ferric derisomaltose (Monoferric) was listed as contraindicated after an acute allergic reaction with throat swelling and generalized itching. This is consistent with a significant hypersensitivity reaction.
What did the hereditary cancer gene panel show?
Clinical-grade genetic testing across a 70-gene panel found no pathogenic variants and no variants of uncertain significance. This is notable despite a strong family history of several cancers.
Which family cancer history was mentioned as significant?
The record describes a multi-generational family history of kidney, colon, pancreatic, and stomach cancers. This history prompted hereditary cancer evaluation.
What role did ECG monitoring play in the source materials?
Serial ECGs, including a critical 12-lead ECG and ambulatory ECGs, were used to document rhythm abnormalities and QT prolongation. These studies were central to identifying the patient’s electrical instability.
What was the purpose of the wearable technology data from Apple Health and Apple Watch?
The wearable data were used to track heart rate variability, stress, and nocturnal oxygen saturation. These measurements can provide supportive information about autonomic stress and sleep-related hypoxemia.
What is the main clinical interpretation of the combination of Long QT, anemia, and hypertension?
Together, these findings suggest a heart under constant stress with both electrical instability and elevated workload. The anemia and hypertension may worsen arrhythmia vulnerability and overall cardiac risk.
Which source types were used to compile the patient’s profile?
The profile was compiled from imaging reports, ECGs, laboratory data, genetic testing, clinical summaries, wearable technology data, and SVT guideline supplements. This reflects a broad, multi-source medical evidence base.
Why are the laboratory findings considered medically important even if some are reactive?
Even reactive leukocytosis and thrombocytosis can signal significant underlying physiologic stress, inflammation, or anemia. In this patient, they help explain the broader systemic illness picture.
What is the significance of the 2015 SVT guideline supplement in the source list?
It provides evidence-based guidance on pharmacologic and catheter-based therapies for supraventricular tachycardia. It serves as a reference framework for evaluating treatment options.
How does the document summarize the patient’s overall condition in cardiovascular terms?
It describes the heart as having both faulty electrical wiring and a failing power grid: Long QT represents the wiring problem, while hypertension and anemia represent the chronic load. This analogy emphasizes combined electrical and hemodynamic risk.
Transformed with Chunk
Think in connected pieces.
Everything you learn, finally connected. Export it all as Markdown, anytime.